EE+ POEM Archive
Likelihood of most adverse treatment outcomes lowest with active surveillance of clinically localized prostate CA (ProtecT)
Likelihood of most adverse treatment outcomes lowest with active surveillance of clinically localized prostate CA (ProtecT) is a topic covered in the EE+ POEM Archive.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Likelihood of Most Adverse Treatment Outcomes Lowest With Active Surveillance of Clinically Localized Prostate CA (ProtecT)." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314139/all/Likelihood_of_most_adverse_treatment_outcomes_lowest_with_active_surveillance_of_clinically_localized_prostate_CA__ProtecT_.
Likelihood of most adverse treatment outcomes lowest with active surveillance of clinically localized prostate CA (ProtecT). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314139/all/Likelihood_of_most_adverse_treatment_outcomes_lowest_with_active_surveillance_of_clinically_localized_prostate_CA__ProtecT_. Accessed April 1, 2023.
Likelihood of most adverse treatment outcomes lowest with active surveillance of clinically localized prostate CA (ProtecT). (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314139/all/Likelihood_of_most_adverse_treatment_outcomes_lowest_with_active_surveillance_of_clinically_localized_prostate_CA__ProtecT_
Likelihood of Most Adverse Treatment Outcomes Lowest With Active Surveillance of Clinically Localized Prostate CA (ProtecT) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2023 April 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314139/all/Likelihood_of_most_adverse_treatment_outcomes_lowest_with_active_surveillance_of_clinically_localized_prostate_CA__ProtecT_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Likelihood of most adverse treatment outcomes lowest with active surveillance of clinically localized prostate CA (ProtecT)
ID - 1314139
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314139/all/Likelihood_of_most_adverse_treatment_outcomes_lowest_with_active_surveillance_of_clinically_localized_prostate_CA__ProtecT_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
